Xeris Biopharma Holdings Inc (XERS)
Stock-Based Compensation
$11.07M
Quarterly · Period ending: · USD
XERS Stock-Based Compensation
Latest reported$11.07Mperiod ending
Latest reported$11.07Mperiod ending
XERS Quarterly Stock-Based Comp ($158.00K → $11.07M)
Quarterly stock-based compensation
High-resolution chart · PNG
XERS stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 11,066,000 | |
| 4,140,000 | |
| 5,272,000 | |
| 7,643,000 | |
| 5,008,000 | |
| 4,443,000 | |
| 3,595,000 | |
| 6,768,000 | |
| 4,233,000 | |
| 3,767,000 | |
| 2,767,000 | |
| 2,457,000 | |
| 2,928,000 | |
| 2,564,000 | |
| 2,766,000 | |
| 2,941,000 | |
| 3,152,000 | |
| 3,301,000 | |
| 2,743,000 | |
| 3,665,000 | |
| 2,512,000 | |
| 2,461,000 | |
| 2,140,000 | |
| 2,054,000 | |
| 2,071,000 | |
| 2,008,000 | |
| 1,842,000 | |
| 1,794,000 | |
| 1,701,000 | |
| 1,147,000 | |
| 579,000 | |
| 544,000 | |
| 361,000 | |
| 244,000 | |
| 148,000 | |
| 104,000 | |
| 89,000 | |
| 158,000 |